One strength of biologicaltreatments for OCD comes from research support which uses randomiseddrugtrials.
Soomro et al (2008) conducted a review of the research examining the effectiveness of SSRIs and found that SSRIs were more effective than placebos in the treatment of OCD.
Biological treatments, including anti-depressants and anti-anxiety drugs, are relatively cost effective in comparison to psychologicaltreatments.
CBT requires a patient to be motivated, drugs however are non-disruptive and can simply be taken until the symptoms subside.
Drugs have many sideeffects.
BZs are renowned for being highly addictive and can also cause increasedaggression and long-term memory impairments.
Drug treatments are criticised for treating the symptoms of the disorder and not the underlying cause.
Drug treatments often just manage the symptoms without dealing with the cause.
Once a patient stops taking medication for OCD, they are prone to relapse.
NICEguidelinesevidence (2014) found non-biological treatments like CBT more effective, with better remissionrates.
Drugtherapy is quick and easy to administer.
The success of drug therapy can vary between individuals.
Sansone & Sansone (2011) found SSRIs significantly reduced symptoms in around 70% of patients.
Bogetto et al (2000) trialled a drug called olanzapine with 23 people with OCD who had not previously responded to SSRIs.
Bogetto et al (2000) found only 10 out of 23 OCD patients responded to olanzapine.
Skapinakis et al (2016) concluded that both cognitive and behavioural therapies were more successful than SSRIs for OCD patients.
Goldacre (2013) suggest that many supporting drug studies are biased as they are sponsored by pharmaceuticalcompanies.